Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
$384.99
$1.56
$4.49
$34.82M0.91607,995 shs290,800 shs
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$22.98
+0.6%
$20.72
$14.40
$47.00
$1.52B1.13959,565 shs676,377 shs
ImmuCell Corporation stock logo
ICCC
ImmuCell
$6.46
+3.2%
$6.29
$3.34
$7.60
$56.57M0.3225,213 shs15,609 shs
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
$12.57
+3.9%
$10.02
$6.19
$15.87
$4.32B4.5728.62 million shs30.43 million shs
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
$0.74
+5.3%
$0.70
$0.48
$3.44
$12.76M0.81.11 million shs14,487 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
0.00%0.00%0.00%0.00%-99.53%
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
+0.57%+2.32%+12.98%+25.57%-42.52%
ImmuCell Corporation stock logo
ICCC
ImmuCell
+3.19%-4.30%+1.73%+17.45%+51.29%
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
+3.88%+2.70%+23.60%+94.58%-1.02%
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
+5.35%-1.22%+19.42%+35.42%-73.59%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
N/AN/AN/AN/AN/AN/AN/AN/A
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
2.4231 of 5 stars
4.41.00.00.03.60.00.0
ImmuCell Corporation stock logo
ICCC
ImmuCell
0.2364 of 5 stars
0.03.00.00.02.20.00.0
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
2.4809 of 5 stars
3.53.00.00.02.81.70.0
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
1.1547 of 5 stars
0.03.00.00.03.31.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
0.00
N/AN/AN/A
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
2.89
Moderate Buy$50.11118.06% Upside
ImmuCell Corporation stock logo
ICCC
ImmuCell
0.00
N/AN/AN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
3.09
Buy$17.3538.03% Upside
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest RIOT, TRIB, CLDX, ICCC, and ABIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.00 ➝ $15.00
6/13/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$50.00
6/13/2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$13.00 ➝ $14.00
5/9/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$44.00 ➝ $38.00
5/9/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$36.00 ➝ $31.00
5/9/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$46.00 ➝ $43.00
5/6/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$80.00 ➝ $80.00
5/2/2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.50 ➝ $12.00
4/28/2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$64.00
4/28/2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$23.00 ➝ $18.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
N/AN/AN/AN/A$2.25 per shareN/A
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$7.02M217.30N/AN/A$11.26 per share2.04
ImmuCell Corporation stock logo
ICCC
ImmuCell
$26.49M2.20$0.07 per share97.36$3.09 per share2.09
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
$376.66M11.92$0.97 per share12.94$9.14 per share1.38
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
$61.56M0.22N/AN/A($1.95) per share-0.38
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
-$5.34M-$0.42N/AN/AN/AN/A-20.18%-19.51%N/A
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
-$157.86M-$2.70N/AN/AN/A-2,366.07%-23.46%-22.35%8/6/2025 (Estimated)
ImmuCell Corporation stock logo
ICCC
ImmuCell
-$2.16M-$0.07N/AN/A-1.00%-1.02%-0.61%8/12/2025 (Estimated)
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
$109.40M-$1.32N/AN/AN/A-86.93%-13.97%-11.99%7/30/2025 (Estimated)
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
-$31.79M-$2.93N/AN/AN/A-68.48%N/A-32.44%8/13/2025 (Estimated)

Latest RIOT, TRIB, CLDX, ICCC, and ABIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025N/A
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
-$0.86N/AN/AN/A$1.13 millionN/A
8/13/2025Q1 2025
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
-$0.51N/AN/AN/AN/AN/A
7/30/2025Q2 2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
-$0.27N/AN/AN/A$146.66 millionN/A
5/14/2025Q1 2025
ImmuCell Corporation stock logo
ICCC
ImmuCell
N/A$0.16N/A$0.16N/A$8.07 million
5/8/2025Q1 2025
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
-$0.75-$0.81-$0.06-$0.81$1.08 million$0.70 million
5/1/2025Q1 2025
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
-$0.25-$0.90-$0.65-$0.90$159.60 million$161.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
N/AN/AN/AN/AN/A
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
N/AN/AN/AN/AN/A
ImmuCell Corporation stock logo
ICCC
ImmuCell
N/AN/AN/AN/AN/A
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
N/AN/AN/AN/AN/A
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
N/A
26.61
26.61
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
N/A
21.67
21.67
ImmuCell Corporation stock logo
ICCC
ImmuCell
0.30
4.12
2.21
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
0.20
3.23
3.23
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
N/A
1.28
0.68

Institutional Ownership

CompanyInstitutional Ownership
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
56.44%
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
N/A
ImmuCell Corporation stock logo
ICCC
ImmuCell
13.47%
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
40.27%
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
78.97%

Insider Ownership

CompanyInsider Ownership
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
30.90%
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
4.40%
ImmuCell Corporation stock logo
ICCC
ImmuCell
6.60%
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
6.93%
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
8.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
ARCA biopharma, Inc. stock logo
ABIO
ARCA biopharma
614.51 million10.02 millionOptionable
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
15066.38 million63.46 millionOptionable
ImmuCell Corporation stock logo
ICCC
ImmuCell
709.04 million8.44 millionNot Optionable
Riot Platforms, Inc. stock logo
RIOT
Riot Platforms
340357.26 million332.51 millionOptionable
Trinity Biotech PLC stock logo
TRIB
Trinity Biotech
48018.05 million16.57 millionOptionable

Recent News About These Companies

Trinity Biotech receives non-compliance notice from Nasdaq
Trinity Biotech zeroes in on CGM
Trinity Biotech announces additional funding for transformation plan

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
ARCA biopharma stock logo

ARCA biopharma NASDAQ:ABIO

ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.

Celldex Therapeutics stock logo

Celldex Therapeutics NASDAQ:CLDX

$22.98 +0.13 (+0.57%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$23.12 +0.14 (+0.61%)
As of 06:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.

ImmuCell stock logo

ImmuCell NASDAQ:ICCC

$6.46 +0.20 (+3.19%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$6.29 -0.17 (-2.62%)
As of 07/16/2025 04:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Riot Platforms stock logo

Riot Platforms NASDAQ:RIOT

$12.57 +0.47 (+3.88%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$12.53 -0.04 (-0.30%)
As of 07:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. The company operates through three segments: Bitcoin Mining, Data Center Hosting, and Engineering. It also provides co-location services for institutional-scale bitcoin mining companies; critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners; operation of data centers; and maintenance/management of computing capacity. In addition, the company engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; and electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial, and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

Trinity Biotech stock logo

Trinity Biotech NASDAQ:TRIB

$0.74 +0.04 (+5.35%)
Closing price 07/16/2025 03:59 PM Eastern
Extended Trading
$0.74 +0.00 (+0.03%)
As of 05:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.